jyoung
09-08-2009, 09:11 PM
Opexa Therapeutics Inc. (Public, NASDAQ:OPXA) zoomed by 105.39% compared to their last month of 65.67% is amongst the top percentage gainers. The stock is being traded at $3.14 with a huge volume of 2.33 million shares. Today, Opexa Therapeutics Inc. announced results from further analysis of the double-blind, placebo-controlled, 52-week Phase IIb TERMS clinical study of 150 patients with Relapsing Remitting MS (RRMS). This analysis evaluated patients with an annualized relapse rate of one or greater at study entry (ARR?1). More than 83% of the Tovaxin-treated group (n=85) remained relapse free at one year and the annualized relapse rate after treatment decreased to 0.20…...
check out LiquidTycoon dot com bcuz they have a summary report on the company...very informative site!
check out LiquidTycoon dot com bcuz they have a summary report on the company...very informative site!